United States· US:62135-806_42c9ddc6-1aae-a645-e063-6294a90a8b1a

PIOGLITAZONE HYDROCHLORIDE

A pioglitazone product containing pioglitazone hydrochloride, registered in United States by Chartwell RX, LLC. The same ATC class is registered in 18 of our 19 countries.

ATC A10BG03US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pioglitazone hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pioglitazone is registered in 18 of 19 countries.

Countries holding a registration under ATC A10BG03 (pioglitazone), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
10 of them publish a price we can compare per daily dose

Search pioglitazone products by name

Pioglitazone · ATC A10BG03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pioglitazone costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.11 in United States to $1.64 in Switzerland — a ×14 gap.

United States: $0.11 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Pioglitazone · price per daily dose (30 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.64
ES Spain$1.22
IT Italy$0.81
US United States$0.11 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: PIOGLITAZONE HYDROCHLORIDE
Manufacturer: Chartwell RX, LLC
Country: United States (US)
ATC code: A10BG03
ATC class: Pioglitazone
Defined daily dose: 30 mg, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 4

ndc11
62135-806-30
ndc11
62135-806-90
ndc11
6213580630
30 TABLET in 1 BOTTLE (62135-806-30)
ndc11
6213580690
90 TABLET in 1 BOTTLE (62135-806-90)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

732 interactions on record for pioglitazone.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pioglitazone against other medicines How interaction checks work

Pioglitazone · interactions on record

732 records

11 severe
302 moderate
63 minor
355 info

Most severe, free to view

ClopidogrelB01AC04severe
GemfibrozilC10AB04severe
MipomersenC10AX11severe
LomitapideC10AX12severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pioglitazone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pioglitazone products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

Bulgaria · Pioglitazone Sanovel, Пизона
Cyprus · Zipion
Czechia · Novapio, Pioglitazon Viatris
Germany · Pioglitazon Aurobindo
Spain · Pioglitazona Aurovitas, Pioglitazona Cinfa
United Kingdom (Northern Ireland) · Pioglitazone Brown And Burk Uk Ltd, Pioglitazone Generics
Greece · Glitact, Raglitan
Croatia · Novapio, Pioglitazon Pliva
Iceland · Actos, Pioglitazone Accord
Italy · Pioglitazone Aurobindo, Pioglitazone Doc Generici
Liechtenstein · Actos, Pioglitazone Accord
Latvia · Zipion
Malta · Novapio
Netherlands · Pioglitazone Hydrochloride Aurobindo, Pioglitazone Sanovel
Norway · Actos, Pioglitazone Accord
Poland · Pioglitazone Bioton
Portugal · Pioglitazona Atrolex, Pioglitazona Aurovitas
Sweden · Pioglitazone Holsten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c216bb28-a06b-44e6-a762-7789a2fda5b6
GET /v1/drugs/c216bb28-a06b-44e6-a762-7789a2fda5b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "45",
  "substance": "PIOGLITAZONE HYDROCHLORIDE",
  "productndc": "62135-806",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA076798",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about pioglitazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console